NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

Search

Coloplast A-S (Class B)

Fermé

442 1.1

Résumé

Variation du prix de l'action

24h

Actuel

Min

437.6

Max

442.1

Chiffres clés

By Trading Economics

Revenu

522M

1.4B

Ventes

83M

7B

P/E

Moyenne du Secteur

24.901

56.063

BPA

6.32

Rendement du dividende

5.27

Marge bénéficiaire

19.835

Employés

16,983

EBITDA

309M

2.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.27%

2.45%

Prochains Résultats

12 mai 2026

Date du Prochain Dividende

20 mai 2026

Date du Prochain Détachement de Dividende

18 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-19B

99B

Ouverture précédente

440.9

Clôture précédente

442

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

1 avr. 2026, 22:56 UTC

Principaux Événements d'Actualité

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1 avr. 2026, 20:50 UTC

Acquisitions, Fusions, Rachats

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1 avr. 2026, 23:55 UTC

Market Talk

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1 avr. 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1 avr. 2026, 23:23 UTC

Principaux Événements d'Actualité

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1 avr. 2026, 23:07 UTC

Résultats

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1 avr. 2026, 23:02 UTC

Principaux Événements d'Actualité

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1 avr. 2026, 23:00 UTC

Principaux Événements d'Actualité

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1 avr. 2026, 23:00 UTC

Principaux Événements d'Actualité

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1 avr. 2026, 23:00 UTC

Principaux Événements d'Actualité

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1 avr. 2026, 22:39 UTC

Résultats

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1 avr. 2026, 22:08 UTC

Market Talk

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1 avr. 2026, 22:00 UTC

Principaux Événements d'Actualité

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1 avr. 2026, 22:00 UTC

Principaux Événements d'Actualité

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1 avr. 2026, 22:00 UTC

Principaux Événements d'Actualité

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1 avr. 2026, 22:00 UTC

Principaux Événements d'Actualité

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1 avr. 2026, 22:00 UTC

Principaux Événements d'Actualité

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1 avr. 2026, 22:00 UTC

Principaux Événements d'Actualité

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1 avr. 2026, 22:00 UTC

Principaux Événements d'Actualité

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1 avr. 2026, 21:56 UTC

Acquisitions, Fusions, Rachats

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1 avr. 2026, 21:31 UTC

Principaux Événements d'Actualité

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1 avr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 avr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1 avr. 2026, 20:38 UTC

Résultats

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1 avr. 2026, 20:31 UTC

Acquisitions, Fusions, Rachats

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1 avr. 2026, 20:16 UTC

Acquisitions, Fusions, Rachats

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1 avr. 2026, 20:16 UTC

Acquisitions, Fusions, Rachats

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1 avr. 2026, 20:13 UTC

Acquisitions, Fusions, Rachats

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1 avr. 2026, 20:07 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1 avr. 2026, 20:07 UTC

Acquisitions, Fusions, Rachats

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat